Ligand validation:6TK7

LFA: EICOSANE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6TK7_LFA_A_307	36%	70%	0.113	0.869	0.4	0.74	-	-	1	0	65%	0.65
6TK7_LFA_A_305	28%	81%	0.13	0.908	0.36	0.46	-	-	0	0	30%	0.3
6TK7_LFA_A_313	28%	77%	0.106	0.889	0.39	0.52	-	-	1	0	25%	0.25
6TK7_LFA_A_302	27%	69%	0.114	0.797	0.39	0.78	-	-	3	0	80%	0.8
6TK7_LFA_A_303	26%	73%	0.153	0.901	0.34	0.68	-	-	0	0	40%	0.252
6TK7_LFA_A_304	26%	78%	0.116	0.88	0.39	0.49	-	-	0	0	30%	0.3
6TK7_LFA_A_320	24%	78%	0.074	0.833	0.36	0.51	-	-	0	0	25%	0.25
6TK7_LFA_A_319	23%	79%	0.112	0.856	0.45	0.41	-	-	0	0	30%	0.3
6TK7_LFA_A_308	22%	70%	0.149	0.85	0.33	0.81	-	-	0	0	50%	0.5
6TK7_LFA_A_326	21%	72%	0.159	0.854	0.35	0.69	-	-	2	0	50%	0.5
6TK7_LFA_A_317	17%	73%	0.203	0.879	0.36	0.66	-	-	0	0	45%	0.45
6TK7_LFA_A_327	13%	70%	0.196	0.804	0.37	0.77	-	-	0	0	60%	0.6
6TK7_LFA_A_309	12%	74%	0.183	0.817	0.39	0.59	-	-	0	0	40%	0.4
6TK7_LFA_A_312	11%	71%	0.12	0.674	0.4	0.71	-	-	3	0	80%	0.8
6TK7_LFA_A_310	11%	74%	0.226	0.847	0.41	0.57	-	-	1	0	40%	0.4
6TK7_LFA_A_325	9%	72%	0.252	0.847	0.36	0.7	-	-	0	0	45%	0.45
6TK7_LFA_A_321	7%	70%	0.274	0.87	0.46	0.67	-	-	0	0	20%	0.2
6TK7_LFA_A_323	6%	73%	0.195	0.711	0.35	0.66	-	-	1	0	50%	0.5
6TK7_LFA_A_322	4%	78%	0.256	0.76	0.4	0.47	-	-	0	0	30%	0.3
6TK7_LFA_A_318	4%	78%	0.243	0.71	0.42	0.45	-	-	1	0	45%	0.45
6TK7_LFA_A_315	3%	79%	0.275	0.739	0.41	0.44	-	-	0	0	25%	0.25
6TK7_LFA_A_314	1%	73%	0.263	0.582	0.45	0.56	-	-	0	0	50%	0.5
6TK7_LFA_A_311	1%	71%	0.179	0.474	0.42	0.67	-	-	0	0	60%	0.6
6TK7_LFA_A_306	1%	80%	0.259	0.599	0.34	0.49	-	-	1	0	25%	0.25
6TK7_LFA_A_316	1%	73%	0.4	0.623	0.41	0.62	-	-	2	0	55%	0.55
6RF6_LFA_A_307	50%	79%	0.101	0.904	0.23	0.62	-	-	0	0	70%	0.7
4XTL_LFA_A_315	46%	89%	0.079	0.949	0.26	0.38	-	-	1	0	25%	0.25
4XTN_LFA_J_311	43%	74%	0.092	0.958	0.38	0.61	-	-	1	0	20%	0.2
6XYT_LFA_C_309	41%	100%	0.165	0.878	0.07	0.05	-	-	0	0	100%	1
6RFC_LFA_A_336	39%	87%	0.105	0.92	0.24	0.46	-	-	0	0	40%	0.4
6SU4_LFA_X_616	66%	100%	0.113	0.917	0.09	0.1	-	-	0	0	100%	1
7AKY_LFA_A_403	58%	99%	0.088	0.911	0.08	0.14	-	-	5	0	75%	0.75
8QLF_LFA_A_408	55%	100%	0.083	0.933	0.1	0.06	-	-	1	0	55%	0.55
4HYJ_LFA_B_302	48%	74%	0.164	0.962	0.2	0.79	-	-	1	0	70%	0.7
7Z09_LFA_A_801	40%	75%	0.087	0.914	0.37	0.58	-	-	1	0	35%	0.35

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.